- Home
- ALOT vs IKNA Comparison
ALOT vs IKNA Comparison
Compare ALOT & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALOT
- IKNA
- Stock Information
- Founded
- ALOT 1969
- IKNA 2016
- Country
- ALOT United States
- IKNA United States
- Employees
- ALOT N/A
- IKNA N/A
- Industry
- ALOT Computer peripheral equipment
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- ALOT Technology
- IKNA Health Care
- Exchange
- ALOT Nasdaq
- IKNA Nasdaq
- Market Cap
- ALOT 84.0M
- IKNA 81.6M
- IPO Year
- ALOT N/A
- IKNA 2021
- Fundamental
- Price
- ALOT $11.49
- IKNA $1.39
- Analyst Decision
- ALOT
- IKNA Buy
- Analyst Count
- ALOT 0
- IKNA 2
- Target Price
- ALOT N/A
- IKNA $3.00
- AVG Volume (30 Days)
- ALOT 5.6K
- IKNA 167.1K
- Earning Date
- ALOT 03-21-2025
- IKNA 03-11-2025
- Dividend Yield
- ALOT N/A
- IKNA N/A
- EPS Growth
- ALOT 12.82
- IKNA N/A
- EPS
- ALOT 0.51
- IKNA N/A
- Revenue
- ALOT $153,515,000.00
- IKNA $659,000.00
- Revenue This Year
- ALOT N/A
- IKNA N/A
- Revenue Next Year
- ALOT N/A
- IKNA N/A
- P/E Ratio
- ALOT $22.69
- IKNA N/A
- Revenue Growth
- ALOT 3.48
- IKNA N/A
- 52 Week Low
- ALOT $11.00
- IKNA $1.22
- 52 Week High
- ALOT $18.25
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- ALOT 43.30
- IKNA 43.10
- Support Level
- ALOT $11.55
- IKNA $1.40
- Resistance Level
- ALOT $12.26
- IKNA $1.53
- Average True Range (ATR)
- ALOT 0.34
- IKNA 0.06
- MACD
- ALOT 0.08
- IKNA 0.00
- Stochastic Oscillator
- ALOT 36.36
- IKNA 28.57
About ALOT AstroNova Inc.
AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.